Supplementary Figure 2 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Authors :: J. Joshua Smith
Jinru Shia
Marios Giannakis
Julio Garcia-Aguilar
Charles L. Sawyers
Rona Yaeger
Punita Dhawan
Nancy E. Kemeny
Karuna Ganesh
Andrea Cercek
Reiko Nishihara
Andrew T. Chan
Kentaro Inamura
Keisuke Kosumi
Tsuyoshi Hamada
Jonathan N. Glickman
Peter Ntiamoah
Arthur E. Elghouayel
Srijaya Prakash Babu Uppada
Katia Manova-Todorova
Afsar Barlas
Leonard Saltz
Garrett M. Nash
Martin R. Weiser
Philip B. Paty
Jose G. Guillem
Bryan Szeglin
Eran Sadot
Jashodeep Datta
Xi Chen
Chao Wu
Michael R. Marco
Shuji Ogino
Lik Hang Lee
Isaac Wasserman
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Kaplan-Meier graph with number of subjects at risk comparing (a) SMAD4, (b) TIL, and (c) PLA status, separately, as well as (d) SMAD4 and TIL, and (e) SMAD4 and PLA, together, with recurrence-free survival (RFS) among only the MMR-proficient patients.

Tools